← Open Payments lookup

MARGARET AUSTIN: Open Payments

NPI 1598131765 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,461 in 37 payments from 14 companies in 2025. Trend: 2023 $1,334 · 2024 $845 · 2025 $1,461

Food & beverage: $1,461
CompanyPaymentsAmount
Novo Nordisk Inc6$341
Lilly USA, LLC11$212
Madrigal Pharmaceuticals2$157
AstraZeneca Pharmaceuticals LP1$135
BETA BIONICS, INC.1$119
Dexcom, Inc.1$118
BridgeBio Pharma, Inc.1$109
Amgen Inc.5$93
Xeris Pharmaceuticals, Inc.3$56
Globus Medical, Inc.2$31

Products named: Ozempic, MOUNJARO, REZDIFFRA, Wegovy, FARXIGA, iLet Bionic Pancreas, DEXCOM G7 GSS (161), Attruby.

Industry payments across MD — which companies pay providers there.